Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Richard

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
Physiological Reports|March 22, 2017
Hip region muscular dystrophy and emergence of motor deficits in dysferlin-deficient Bla/J miceNadia Nagy, Randal J Nonneman, Telmo Llanga, et al.
Traffic (Copenhagen, Denmark)|November 30, 2006
Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defectJyoti K Jaiswal, Gareth Marlow, Gillian Summerill, et al.
Scientific Reports|March 29, 2024
Author Correction: miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophyMathilde Sanson, Ai Vu Hong, Emmanuelle Massourides, et al.
JCI Insight|March 23, 2026
DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulationCeline Bruge, Nathalie Bourg, Emilie Pellier, et al.
Scientific Reports|June 6, 2020
miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophyMathilde Sanson, Ai Vu Hong, Emmanuelle Massourides, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2023
Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscleAdrien Morin, Amalia Stantzou, Olga N Petrova, et al.
Frontiers in Pharmacology|May 16, 2022
Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat CombinationLucile Hoch, Nathalie Bourg, Fanny Degrugillier, et al.
Annals of Neurology|January 8, 2014
Atypical phenotypes in titinopathies explained by second titin mutationsAnni Evilä, Anna Vihola, Jaakko Sarparanta, et al.
Science (New York, N.Y.)|April 2, 2005
The kinase domain of titin controls muscle gene expression and protein turnoverStephan Lange, Fengqing Xiang, Andrey Yakovenko, et al.
American Journal of Human Genetics|January 26, 2010
Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophiesVéronique Bolduc, Gareth Marlow, Kym M Boycott, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Physiological Reports|March 22, 2017
Hip region muscular dystrophy and emergence of motor deficits in dysferlin-deficient Bla/J miceNadia Nagy, Randal J Nonneman, Telmo Llanga, et al.
Traffic (Copenhagen, Denmark)|November 30, 2006
Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defectJyoti K Jaiswal, Gareth Marlow, Gillian Summerill, et al.
Scientific Reports|March 29, 2024
Author Correction: miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophyMathilde Sanson, Ai Vu Hong, Emmanuelle Massourides, et al.
JCI Insight|March 23, 2026
DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulationCeline Bruge, Nathalie Bourg, Emilie Pellier, et al.
Scientific Reports|June 6, 2020
miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophyMathilde Sanson, Ai Vu Hong, Emmanuelle Massourides, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2023
Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscleAdrien Morin, Amalia Stantzou, Olga N Petrova, et al.
Frontiers in Pharmacology|May 16, 2022
Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat CombinationLucile Hoch, Nathalie Bourg, Fanny Degrugillier, et al.
Annals of Neurology|January 8, 2014
Atypical phenotypes in titinopathies explained by second titin mutationsAnni Evilä, Anna Vihola, Jaakko Sarparanta, et al.
Science (New York, N.Y.)|April 2, 2005
The kinase domain of titin controls muscle gene expression and protein turnoverStephan Lange, Fengqing Xiang, Andrey Yakovenko, et al.
American Journal of Human Genetics|January 26, 2010
Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophiesVéronique Bolduc, Gareth Marlow, Kym M Boycott, et al.
Pageof 19